NOS3 and endothelial dysfunction: A previous study showed that BBR treatment reduces plasma TG levels, increases eNOS mRNA and protein expression and serum NO levels, improves endothelium-dependent vasorelaxation in the aorta, and restores endothelial dysfunction in diabetic rats (Wang et al., 2009b).